Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers.
Journal of psychopharmacology (Oxford, England) January 1, 2023 Brent Kious, Zach Schwartz, Benjamin Lewis 44 citations
Personal use of psychedelics by researchers may threaten objectivity and ethical conduct in psychedelic science. The paper explores whether such use can make investigators overly enthusiastic about psychedelics, potentially biasing study design, results reporting, and treatment of participants. Critiques of the MAPS MDMA-Assisted Therapy trials for PTSD have raised similar concerns. The authors elaborate on these risks and discuss practical strategies to reduce perceived conflicts of interest, aiming to inform policy for psychedelic research and clinical use.